Chronic lymphocytic leukemia in China.
作者信息
Gale Robert Peter
机构信息
Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London SW7 2AZ, UK.
出版信息
Chin Med J (Engl). 2022 Apr 20;135(8):883-886. doi: 10.1097/CM9.0000000000001811.
Abstract
摘要
相似文献
1
Chronic lymphocytic leukemia in China.中国的慢性淋巴细胞白血病
Chin Med J (Engl). 2022 Apr 20;135(8):883-886. doi: 10.1097/CM9.0000000000001811.
2
Complications of chronic lymphocytic leukemia: analysis of 203 cases in China.慢性淋巴细胞白血病的并发症：中国203例病例分析
Leuk Res. 2010 Feb;34(2):e64-5. doi: 10.1016/j.leukres.2009.07.041. Epub 2009 Aug 21.
3
Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study.泽布替尼治疗复发/难治性慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的疗效：一项 2 期、单臂、多中心研究。
J Hematol Oncol. 2020 May 11;13(1):48. doi: 10.1186/s13045-020-00884-4.
4
Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China.中国上海的既往病史与成人白血病风险
Cancer Causes Control. 1993 Jul;4(4):361-8. doi: 10.1007/BF00051339.
5
Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma.慢性淋巴细胞白血病对恶性黑色素瘤的发生发展的影响。
Dermatol Surg. 2010 Mar;36(3):368-76. doi: 10.1111/j.1524-4725.2009.01447.x. Epub 2010 Jan 19.
6
Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia.中国和意大利慢性淋巴细胞白血病患者的免疫球蛋白基因重排
Oncotarget. 2016 Apr 12;7(15):20520-31. doi: 10.18632/oncotarget.7819.
7
Why a Special Issue on Chronic Lymphocytic Leukemia?为什么要有一期关于慢性淋巴细胞白血病的特刊？
Cancer Control. 2015 Oct;22(4 Suppl):2. doi: 10.1177/107327481502204s01.
8
[Occurrence of associated tumours in chronic lymphocytic leukemia].[慢性淋巴细胞白血病相关肿瘤的发生情况]
Orv Hetil. 2016 Oct;157(44):1752-1756. doi: 10.1556/650.2016.30551.
9
Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia.慢性粒细胞白血病患者中慢性淋巴细胞白血病的发生情况。
Indian J Pathol Microbiol. 2013 Jul-Sep;56(3):188-9. doi: 10.4103/0377-4929.120357.
10
Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials.慢性淋巴细胞白血病合并症与治疗之间的相互作用：德国慢性淋巴细胞白血病研究组试验结果
Haematologica. 2014 Jun;99(6):1095-100. doi: 10.3324/haematol.2013.096792. Epub 2014 Feb 28.
引用本文的文献
1
Comparative analysis of patients' characteristics, treatment, and survival outcomes in CLL from China and the United States.中国和美国慢性淋巴细胞白血病患者特征、治疗及生存结局的比较分析。
Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyaf181.
2
Chimeric antigen receptor (CAR) -T cell therapy treatment Richter's transformation.嵌合抗原受体（CAR）-T细胞疗法治疗里氏转化。
Front Oncol. 2025 Jun 9;15:1591360. doi: 10.3389/fonc.2025.1591360. eCollection 2025.
3
Pirtobrutinib in Chinese patients with relapsed or refractory B-cell malignancies: A single-arm, open-label, phase 2, multicenter trial.泽布替尼治疗复发或难治性B细胞恶性肿瘤中国患者：一项单臂、开放标签、2期、多中心试验。
Int J Cancer. 2025 Jun 1;156(11):2158-2168. doi: 10.1002/ijc.35339. Epub 2025 Feb 28.
4
Type II cryoglobulinemia in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma and Sjögren's disease.伴有干燥综合征的慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的 II 型冷球蛋白血症。
J Int Med Res. 2024 Nov;52(11):3000605241285228. doi: 10.1177/03000605241285228.
5
A 47-Year-old Asian female with tracheobronchial space-occupying lesions caused by chronic lymphocytic leukemia.一位 47 岁的亚裔女性，患有慢性淋巴细胞白血病导致的气管支气管腔占位性病变。
BMC Pulm Med. 2024 Oct 14;24(1):514. doi: 10.1186/s12890-024-03330-0.
6
Clinician Perspective on Once-Daily Zanubrutinib Dosing for B-Cell Malignancies at a Single Center.单中心临床医生对泽布替尼每日一次给药治疗B细胞恶性肿瘤的观点
Clin Med Insights Oncol. 2024 Sep 4;18:11795549241275665. doi: 10.1177/11795549241275665. eCollection 2024.
7
Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE.在复发/难治性慢性淋巴细胞白血病（R/R CLL）患者中，与伊布替尼相比，zanubrutinib 的疗效和安全性得到改善：ALPINE 的一个亚组。
Ann Hematol. 2024 Oct;103(10):4183-4191. doi: 10.1007/s00277-024-05823-8. Epub 2024 Jun 18.
8
Knowledge, attitude, and practice toward leukemia in the general population and among family members of patients with leukemia: A cross-sectional study.普通人群及白血病患者家庭成员对白血病的认知、态度和行为：一项横断面研究。
Heliyon. 2024 Feb 10;10(5):e26276. doi: 10.1016/j.heliyon.2024.e26276. eCollection 2024 Mar 15.
9
Global miRNA profiling reveals key molecules that contribute to different chronic lymphocytic leukemia incidences in Asian and Western populations.全球 miRNA 谱分析揭示了导致亚洲和西方人群慢性淋巴细胞白血病发病率不同的关键分子。
Haematologica. 2024 Feb 1;109(2):479-492. doi: 10.3324/haematol.2023.283181.
10
Perspectives on the Application of Cytogenomic Approaches in Chronic Lymphocytic Leukaemia.细胞基因组学方法在慢性淋巴细胞白血病中的应用前景
Diagnostics (Basel). 2023 Mar 3;13(5):964. doi: 10.3390/diagnostics13050964.
Zotero 插件